Changes Of Rupi Decoction On Hyperplasia Of Mammary Glands In Observation Of Curative Effect And The Levels Of Estrogen And Progesterone

Objective:This study aims to investigate the Shiquandabutang subtraction to alleviate the Yin Deficiency type of non-small cell lung cancer clinical efficacy(Blood deficiency syndrome) due to adverse reactions were observed.Methods:Selected 90 patients as a study in the Third Affiliated Hospital of Qiqihar Medical University from January 2013 to December 2014, had a clear pathological diagnosis of non-small cell lung cancer.53 cases of squamous cell carcinoma, adenocarcinoma,37 cases of clinical stage Ⅲ 47 cases of stage IV 43 cases,49 males and 41 females, aged 31-75 years, mean 54.9 years old, were divided into three groups. Treatment groups:30 cases.Selected Shiquandabutang subtraction morning and evening, half an hour after a meal, warm clothes, from one week to begin serving before chemotherapy, after the end of chemotherapy cycles to continue serving one weeks; group A:30 cases.Conventional amine or white, shark liver alcohol, prescribed oral dose of vitamin B4 to continue serving after chemotherapy cycle one weeks group B:30 cases.Shiquandabutang Cuba morning and evening, half an hour after a meal, warm clothes, from one week to begin serving before chemotherapy to chemotherapy cycle ends continue to serve after one weeks. After observing Shiquandabutang decoction before treatment, clinical symptoms and changes in blood were compared with the control group, in order to clarify Shiquandabutang subtraction to reduce the side effects of chemotherapy, reliability, reflecting Shiquandabutang After the reduction of bone marrow suppression and mitigation of adverse effects than conventional superiority of treatment for lung cancer after chemotherapy.Results: Compare the adverse reactions to chemotherapy remission, three groups had significant difference as follows:the kappa score (F= 10.067; P= 0.002), physical(x2= 8.978,P= 0.011), inappetence (x2= 8.233, P=0.016), insomnia (x2=16.717, P= 0.000),stomachache (x2-6.720, P= 0.035),myelosuppression (x2= 5.929, P= 0.037), constipation (x2=2.985, P= 0.381),abdominal distension (x2=1-495, P= 0.473),nausea and vomiting (x2=2-899, P= 0.235) didn’t have the significant difference.Conclusions:1. Shiquandabutang therapy can improve physical status of non-small cell lung cancer patients after chemotherapy.2. Shiquandabutang therapy can reduce the degree of bone marrow depression after chemotherapy in patients with non-small cell lung cancer.3. Shiquandabutang therapy can reduce the partial gastrointestinal toxicity of non-small cell lung cancer patients after chemotherapy.4.Shiquandabutang symptomatic compared with conventional Western medicine and subtraction Shiquandabutang ancient square in mitigating non-small cell lung cancer patients after chemotherapy, bone marrow suppression and other adverse reactions and improve mental state, physical and so more advantages...